Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil Citrate for Fetal Growth Restriction
NCT03177824Phase 3Unknown
- Sponsor
- Ain Shams University
- Start
- Mar 2017
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ASP-001 in fetal growth restriction (FGR) (2 arms), sponsored by Ain Shams University. Primary endpoint: Date of delivery after Sildenafil citrate administration at 6 months. Status: unknown.
02
Drugs
ASP-001
03
Conditions
fetal growth restriction (FGR)
Beyond the preview
Go deeper on NCT03177824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03177824.